CEMVX
Price
$19.31
Change
+$0.17 (+0.89%)
Updated
Sep 11 closing price
Net Assets
4.13B
RNWHX
Price
$107.05
Change
-$0.71 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
Interact to see
Advertisement

CEMVX vs RNWHX

CEMVX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
CEMVX vs. RNWHX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEMVX is a Hold and RNWHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90B vs. CEMVX (4.13B). RNWHX pays higher dividends than CEMVX: RNWHX (1.15) vs CEMVX (0.78). CEMVX was incepted earlier than RNWHX: CEMVX (19 years) vs RNWHX (11 years). CEMVX (1.34) is less costly to investors than RNWHX (0.72). CEMVX is a more actively managed with annual turnover of: 92.00 vs. RNWHX (46.00). RNWHX has a lower initial minimum investment than CEMVX: RNWHX (250) vs CEMVX (5000). CEMVX annual gain was more profitable for investors over the last year : 37.45 vs. RNWHX (17.19). CEMVX return over 5 years is better than : 42.51 vs. RNWHX (17.68).
CEMVXRNWHXCEMVX / RNWHX
Total Expense Ratio1.340.72186%
Annual Report Gross Expense Ratio1.340.72186%
Fund Existence19 years11 years-
Gain YTD30.29316.447184%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRA4000N/A-
Net Assets4.13B90B5%
Annual Yield % from dividends0.781.1568%
Returns for 1 year37.4517.19218%
Returns for 3 years113.3853.84211%
Returns for 5 years42.5117.68240%
Returns for 10 years125.96111.44113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPEX46.310.28
+0.61%
Fidelity Advisor Low-Priced Stock C
FACDX64.25N/A
N/A
Fidelity Advisor Health Care A
EXHAX26.61N/A
N/A
Manning & Napier Pro-Blend Max Term S
LMCFX35.98N/A
N/A
Lord Abbett Mid Cap Stock F
MSAWX22.51N/A
N/A
Morgan Stanley Inst Asia Opp C